Robin L Anderson Selected Research

Robin L Anderson Research Topics

Disease

38	Neoplasms (Cancer) 05/2022 - 10/2004
35	Breast Neoplasms (Breast Cancer) 05/2022 - 10/2004
33	Neoplasm Metastasis (Metastasis) 11/2022 - 10/2004
3	Neutropenia 01/2021 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 01/2015
2	Triple Negative Breast Neoplasms 03/2021 - 01/2020
2	Neoplasm Micrometastasis 01/2017 - 04/2013
2	Inflammation (Inflammations) 01/2017 - 01/2015
1	Disease Progression 11/2022
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 03/2021
1	Circulating Neoplastic Cells 01/2020
1	Febrile Neutropenia 01/2018
1	Infections 01/2018
1	Arthritis (Polyarthritis) 01/2017
1	Pain (Aches) 01/2017
1	Melanoma (Melanoma, Malignant) 01/2015
1	Brain Ischemia (Cerebral Ischemia) 01/2015
1	Retinal Degeneration 01/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2014

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2006
6	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021 - 08/2014
5	Estrogen ReceptorsIBA 01/2017 - 03/2005
4	Caveolin 1IBA 09/2013 - 10/2004
3	Transcription Factors (Transcription Factor)IBA 11/2022 - 01/2015
3	Pharmaceutical PreparationsIBA 05/2022 - 07/2009
3	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 11/2021 - 08/2014
3	ChemokinesIBA 10/2021 - 07/2009
3	Estrogens (Estrogen)FDA Link 01/2017 - 03/2005
3	Endoplasmic Reticulum Chaperone BiPIBA 11/2016 - 02/2012
2	CytokinesIBA 10/2021 - 06/2006
2	Annexin A1IBA 03/2021 - 02/2011
2	Messenger RNA (mRNA)IBA 03/2021 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 06/2006
2	Phenobarbital (Luminal)FDA Link 01/2020 - 06/2009
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2016
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 03/2005
2	IntegrinsIBA 01/2018 - 02/2012
2	Histone Deacetylase InhibitorsIBA 01/2018 - 07/2009
2	Cell Surface ReceptorsIBA 01/2017 - 11/2016
2	Tamoxifen FDA LinkGeneric 03/2015 - 07/2009
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2013 - 02/2012
2	Peptides (Polypeptides)IBA 04/2013 - 12/2011
2	Carrier Proteins (Binding Protein)IBA 02/2011 - 07/2009
1	ChromatinIBA 11/2022
1	Calcibiotic Root Canal SealerIBA 11/2022
1	Cisplatin (Platino)FDA LinkGeneric 05/2022
1	PlatinumIBA 05/2022
1	Epoxy Compounds (Epoxides)IBA 10/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2021
1	AcidsIBA 10/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2021
1	Protein Isoforms (Isoforms)IBA 01/2020
1	fibroblast growth factor 13IBA 01/2020
1	neratinibIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 11/2018
1	nephronectinIBA 01/2018
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2018
1	N8- hydroxy- 2- (1H- indole- 2- carboxamido)- N1- (quinolin- 8- yl)octanediamideIBA 01/2018
1	ZymosanIBA 01/2017
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2017
1	Thymidine KinaseIBA 11/2016
1	Ganciclovir (Cytovene)FDA LinkGeneric 11/2016
1	1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine- vasopressin (AAVP)IBA 11/2016
1	ProdrugsIBA 11/2016
1	Immunoglobulin FragmentsIBA 11/2016
1	Interferon Type IIBA 11/2015
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 11/2015
1	Parathyroid Hormone (Parathormone)IBA 03/2015
1	Hormones (Hormone)IBA 03/2015
1	CD36 AntigensIBA 03/2015
1	Calcium-Binding ProteinsIBA 03/2015
1	tyrosine receptor (receptor, tyrosine)IBA 01/2015
1	Glycoproteins (Glycoprotein)IBA 01/2015
1	Small Interfering RNA (siRNA)IBA 01/2015
1	DNA (Deoxyribonucleic Acid)IBA 01/2015
1	Oncogene Proteins (Oncogene Protein)IBA 01/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2014
1	AntibodiesIBA 08/2014
1	Neutralizing AntibodiesIBA 08/2014
1	Macrophage Colony-Stimulating FactorIBA 08/2014
1	CateninsIBA 09/2013
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 09/2013
1	PeptidomimeticsIBA 04/2013
1	peptide 78IBA 04/2013
1	Actin Depolymerizing Factors (Cofilins)IBA 04/2013
1	Lim KinasesIBA 04/2013
1	Histocompatibility Antigens Class IIIBA 10/2012
1	Interferon Regulatory FactorsIBA 08/2012

Therapy/Procedure

21	Therapeutics 05/2022 - 06/2006
4	Radiotherapy 01/2019 - 07/2010
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
3	Synchrotrons 01/2019 - 07/2010
1	Neoadjuvant Therapy 01/2019
1	Drug Tapering 01/2018
1	Aftercare (After-Treatment) 01/2017
1	Precision Medicine 11/2016